A phenothiazine used as an antipsychotic agent and as an antiemetic.
The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.

Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo. (1/14)

OBJECTIVE: This study was undertaken to assess the role of vascular smooth muscle cell (VSMC) Ca2+ channels and Ca2+/calmodulin-dependent protein kinase II (CaMKII) in gene regulation after oxidative endothelial injury (OEI). METHODS AND RESULTS: OEI was produced by infusion of Na fluorescein (NaFluo) photoactivated by UV light immediately before intravenous injection. Posterior cerebral arteries were studied using immunofluorescence imaging, Western blotting, or patch clamping of isolated cells. After infusion of photoactivated NaFluo, but not NaFluo, (1) superoxide dismutase-1 (SOD-1) was upregulated in endothelium, consistent with oxidant stress; (2) the fraction of VSMC nuclei labeled for proliferating cell nuclear antigen (PCNA) increased 7-fold at 6 hours, preceded by a several-fold increase in nuclear phospho-cAMP-response element binding protein, with PCNA upregulation prevented by pretreatment with polyethylene glycol (PEG)-SOD; (3) in VSMCs, phospho-CaMKII increased 20-fold 5 minutes after OEI, with a 2-fold increase in peak Ca2+ channel currents; and (4) changes in cAMP-response element binding protein and PCNA were blocked by systemic administration of lipophilic (nifedipine) or hydrophilic (amlodipine) 1,4-dihydropyridine Ca2+ channel blockers, the calmodulin inhibitor trifluoperazine, or the CaMKII inhibitor KN-93, with none of these agents preventing SOD-1 upregulation in endothelium. CONCLUSIONS: Activation of VSMC Ca2+ channels and CaMKII is a key early signaling event required for upregulation of PCNA gene expression in VSMCs after oxidative injury to endothelium.  (+info)

Trypanosoma cruzi: effect of phenothiazines on the parasite and its interaction with host cells. (2/14)

Phenothiazines were observed to have a direct effect on Trypanosoma cruzi and on its in vitro interaction with host cells. They caused lysis of trypomastigotes (50 uM/24 h) and, in axenic medium, dose-dependent inhibition of amastigote and, to a lesser extent, epimastigote proliferation. Treatment of infected peritoneal macrophages with 12.5 uM chlorpromazine or triflupromazine inhibited the infection; this effect was found to be partially reversible if the drugs were removed after 24 h of treatment. At 60 uM, the drugs caused damage to amastigotes interiorized in heart muscle cells. However, the narrow margin of toxicity between antitrypanosomal activity and damage to host cells mitigates against in vivo investigation at the present time. Possible hypotheses for the mechanism of action of phenothiazines are discussed.  (+info)

STUDIES ON THE HYPERGLYCAEMIA INDUCED BY CHLORPROMAZINE IN RATS. (3/14)

Chlorpromazine induces in rats a marked and long-lasting hyperglycaemia which (a) is more marked at low than high room temperatures, (b) is inhibited by phentolamine but not by dibenamine, and (c) is prevented by adrenalectomy, by removal of the adrenal medullae and by treatment of the rats with reserpine. Other experimental results suggest that there is a correlation between the hyperglycaemia and the hypothermia induced by chlorpromazine and by its congeners. The hyperglycaemia seems to be the result of at least two factors: an activation of the adrenergic mechanisms and an impaired peripheral utilization of glucose.  (+info)

Dissociation constants of phenothiazine drugs incorporated in phosphatidylcholine bilayer of small unilamellar vesicles as determined by carbon-13 nuclear magnetic resonance spectrometric titration. (4/14)

The dissociation constants (pKms) of the phenothiazine drugs promazine, chlorpromazine, and triflupromazine, incorporated in the phosphatidylcholine (PC) bilayer of small unilamellar vesicles (SUV), were investigated by a 13C nuclear magnetic resonance (NMR) titration method employing their N-13CH3 (ionizable group) labelled derivatives. Use of the labelled drugs enabled direct observations of the ionization equilibrium of the N-dimethyl group. A second derivative spectrophotometric study proved that 95-98% of the phenothiazine species in the sample solutions (200 microM phenothiazine in the presence of 27 mM PC SUV) were incorporated into the PC bilayer, which simplified the calculation of pKm values by allowing that the phenothiazines in the aqueous phase could be neglected. The pKm values were calculated from the chemical shift dependence of the N-dimethyl 13C NMR signal on the pH value of sample solutions. The pKm values obtained were smaller than those measured in aqueous solutions by about one unit. The existence of cholesterol (30 mol%) in the PC bilayer showed little effect on the pKm values, suggesting that cholesterol in the bilayer does not largely affect the interfacial region where the N-dimethyl group of the incorporated phenothiazines is located. The results offered clear evidence for the pKm decrease and provided their precise values.  (+info)

Effects of phosphatidylserine and phosphatidylethanolamine content on partitioning of triflupromazine and chlorpromazine between phosphatidylcholine-aminophospholipid bilayer vesicles and water studied by second-derivative spectrophotometry. (5/14)

To assess the affinity of psychotropic phenothiazine drugs, triflupromazine (TFZ) and chlorpromazine (CPZ), for the membranes of central nervous system and the other organs in the body, the partition coefficients (Kps) of these drugs to phosphatidylcholine (PC)-phosphatidylserine (PS) and PC-phosphatidylethanolamine (PE) small and large unilamellar vesicles (SUV, LUV) were examined by a second-derivative spectrophotometric method, since PS is abundantly contained in the membranes of the central nervous system and PE is distributed widely in the membranes of the organs in the body. Size and preparation methods of the vesicles did not affect the Kp values at each aminophospholipid content suggesting that the partition of the phenothiazine drugs was not affected by the structural differences in the vesicles such as their curvature or asymmetric distribution of the phospholipids between the outer and inner layers of the bilayer membranes. However, the Kp values of both drugs increased remarkably according to the PS content in the bilayer membranes, i.e., the Kp values for the vesicles of 30 mol% PS content were about 3 times of that for the vesicles of PC alone, while both Kp values slightly reduced with the increase in the content of PE in the bilayer membranes of PC-PE vesicles. The results indicate that both drugs have higher affinity for the PC-PS bilayer membranes than for the PC and PC-PE membranes, which can offer an evidence for the fact that TFZ and CPZ are predominantly distributed and accumulated in the brain and nerve cell membranes that contain PS abundantly.  (+info)

Effects of inorganic ions on the binding of triflupromazine and chlorpromazine to bovine serum albumin studied by spectrometric methods. (6/14)

The effects of inorganic salts, NaCl, NaBr, NaI, Na2SO4, KCl, KBr, KI, on the binding constants (Ks) of psychotropic phenothiazine drugs, triflupromazine (TFZ) and chlorpromazine, to bovine serum albumin (BSA) were examined by using second-derivative spectrophotometry. All of the salts examined, with the exception of Na2SO4, decreased the K values significantly, depending on the concentration of the salt, e.g., the decrease in the K values of both drugs were about 40% for 0.1 M NaCl. The results obtained with Na2SO4 indicated that neither Na+ nor SO4(2-) had any affect on the binding of the phenothiazines to BSA. Based on the Na2SO4 results and the finding that the effect of each potassium salt on binding was quite similar to that of the corresponding sodium salt, the effects of these halogen salts can be considered to be derived from their anions, although the phenothiazines are positively charged at pH 7.4. The effectiveness of the anions was determined to occur in the following order: I->>Br->Cl-; these results coincided with the published order of the binding affinity of these anions to albumin. The 19F-NMR spectra of TFZ in the presence of each of these halogen salts revealed a concentration-dependent decrease in the intensity of the signal at 13.8 ppm that had previously been assigned to the TFZ bound to Site II. Consequently, the effects of these anions on the binding of positively charged phenothiazine drugs are thought to be local steric effects caused by the binding of these anions to Site II.  (+info)

Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. (7/14)

 (+info)

Effects of chemical manipulation of mitotic arrest and slippage on cancer cell survival and proliferation. (8/14)

Microtubule-targeting cancer therapies interfere with mitotic spindle dynamics and block cells in mitosis by activating the mitotic checkpoint. Cells arrested in mitosis may remain arrested for extended periods of time or undergo mitotic slippage and enter interphase without having separated their chromosomes. How extended mitotic arrest and mitotic slippage contribute to subsequent cell death or survival is incompletely understood. To address this question, automated fluorescence microscopy assays were designed and used to screen chemical libraries for modulators of mitotic slippage. Chlorpromazine and triflupromazine were identified as drugs that inhibit mitotic slippage and SU6656 and geraldol as chemicals that stimulate mitotic slippage. Using the drugs to extend mitotic arrest imposed by low concentrations of paclitaxel led to increased cell survival and proliferation after drug removal. Cells arrested at mitosis with paclitaxel or vinblastine and chemically induced to undergo mitotic slippage underwent several rounds of DNA replication without cell division and exhibited signs of senescence but eventually all died. By contrast, cells arrested at mitosis with the KSP/Eg5 inhibitor S-trityl-L-cysteine and induced to undergo mitotic slippage were able to successfully divide and continued to proliferate after drug removal. These results show that reinforcing mitotic arrest with drugs that inhibit mitotic slippage can lead to increased cell survival and proliferation, while inducing mitotic slippage in cells treated with microtubule-targeting drugs seems to lead to protracted cell death.  (+info)

Triflupromazine is an antipsychotic medication that belongs to the class of phenothiazines. It works by blocking dopamine receptors in the brain, which helps to reduce psychotic symptoms such as hallucinations, delusions, and hostility.

The medical definition of Triflupromazine is:

A trifluoromethyl phenothiazine antipsychotic drug, with sedative and hypotensive effects. It is used in the management of chronic schizophrenia, agitated states, and severe behavior problems in children. Its side effects include extrapyramidal symptoms (EPS), such as tremors, rigidity, and akathisia, as well as anticholinergic effects like dry mouth and constipation. It may also cause orthostatic hypotension, drowsiness, and weight gain.

Chlorpromazine is a type of antipsychotic medication, also known as a phenothiazine. It works by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis such as hallucinations, delusions, and disordered thinking. Chlorpromazine is used to treat various mental health conditions including schizophrenia, bipolar disorder, and severe behavioral problems in children. It may also be used for the short-term management of severe anxiety or agitation, and to control nausea and vomiting.

Like all medications, chlorpromazine can have side effects, which can include drowsiness, dry mouth, blurred vision, constipation, weight gain, and sexual dysfunction. More serious side effects may include neurological symptoms such as tremors, rigidity, or abnormal movements, as well as cardiovascular problems such as low blood pressure or irregular heart rhythms. It is important for patients to be monitored closely by their healthcare provider while taking chlorpromazine, and to report any unusual symptoms or side effects promptly.

Triflupromazine (Vesprin) is an antipsychotic medication of the phenothiazine class. Among different effects of triflupromazine ... "Triflupromazine". DrugBank. v t e (CS1 German-language sources (de), Articles with short description, Short description matches ... Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not ... Serious side effects of triflupromazine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, ...
Triflupromazine , C18H19F3N2S , CID 5568 - structure, chemical names, physical and chemical properties, classification, patents ...
Triflupromazine. Tables. Demographic and Clinical Characteristics as Well as Diabetes Incidence Among Schizophrenia Patients, ...
... triflupromazine (Vesprin); trimeprazine (Temaril); and vitamins or herbal products. ...
This medicine may make you dizzy, drowsy, or have trouble with thinking or controlling body movements. Do not drive or do anything else that could be dangerous until you know how this medicine affects you. This medicine may cause tardive dyskinesia (a movement disorder). Check with your doctor right away if you have any of the following symptoms while taking this medicine: lip smacking or puckering, puffing of the cheeks, rapid or worm-like movements of the tongue, uncontrolled chewing movements, or uncontrolled movements of the arms and legs. The risk of tardive dyskinesia is higher if you take this medicine for longer than 12 weeks. Treatment for longer than 12 weeks should be avoided in all but rare cases. Tell your doctor right away if you have the following symptoms while you are using this medicine: inability to move the eyes, increased blinking or spasms of the eyelid, trouble with breathing, speaking, or swallowing, uncontrolled tongue movements, uncontrolled twisting movements of the ...
Detailed drug Information for Zydone. Includes common brand names, drug descriptions, warnings, side effects and dosing information.
Do not use this medicine if you are using or have used an MAO inhibitor (MAOI) such as Eldepryl®, Marplan®, Nardil®, or Parnate® within the past 14 days. This medicine may be habit-forming. If you feel that the medicine is not working as well, do not use more than your prescribed dose. Call your doctor for instructions. This medicine may make you dizzy or drowsy. Do not drive or do anything else that could be dangerous until you know how this medicine affects you. Check with your doctor before using this medicine with alcohol or other medicines that affect the central nervous system (CNS). The use of alcohol or other medicines that affect the CNS may worsen the side effects of this medicine, such as dizziness, poor concentration, drowsiness, unusual dreams, and trouble with sleeping. Some examples of medicines that affect the CNS are antihistamines or medicine for allergies or colds, sedatives, tranquilizers, or sleeping medicines, medicine for depression, medicine for anxiety, prescription ...
Detailed drug Information for Dazidox. Includes common brand names, drug descriptions, warnings, side effects and dosing information.
Triflupromazine hydrochloride (JAN/USP). D00817 Bupropion hydrochloride (JAN/USP). D00826 Tranylcypromine sulfate (USP). ...
A comparative study of promazine and triflupromazine in the treatment of acute alcoholism. Dis Nerv Syst. 1960;21:32-38. PubMed ... in 1960 that patients with mild-to-moderate symptoms of alcohol withdrawal responded to either promazine or triflupromazine, ...
Antiviral activity of chlorpromazine hydrochloride and triflupromazine hydrochloride. (A) Chemical structures of the compounds ... Antiviral activity of chlorpromazine hydrochloride and triflupromazine hydrochloride. (A) Chemical structures of the… ... or triflupromazine hydrochloride (C). Antiviral activity is shown in blue, and cytotoxicity is shown in red. EC50s are ...
PHENOTHIAZINES IN THE TREATMENT OF NEWLY ADMITTED STATE HOSPITAL PATIENTS: GLOBAL COMPARISON OF EIGHT COMPOUNDS IN TERMS OF AN OUTCOME INDEX
Triflupromazine,N0000006126, Dexamethasone,N0000006127, Bromelains,N0000006128, Rauwolfia Alkaloids,N0000006129, bentiromide, ...
1. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced ...
... triflupromazine, chlorpromazine, chlorpromazine, promazine, Q or p-flupenthixol, cis or trans-thiothixene on GABA uptake and ...
Triflupromazine (substance). Code System Preferred Concept Name. Triflupromazine (substance). Concept Status. Published. ...
Triflupromazine D3.494.741.918 D3.633.300.741.918 Trigger Finger Disorder C5.651.869.870.800.800 C5.651.869.816.800 Trillium ...
Triflupromazine Preferred Term Term UI T041786. Date01/01/1999. LexicalTag NON. ThesaurusID ... Triflupromazine Preferred Concept UI. M0021962. Registry Number. RO16TQF95Y. Related Numbers. 146-54-3. Scope Note. A ... Triflupromazine. Tree Number(s). D02.886.369.918. D03.633.300.783.918. Unique ID. D014273. RDF Unique Identifier. http://id.nlm ...
Triflupromazine Preferred Term Term UI T041786. Date01/01/1999. LexicalTag NON. ThesaurusID ... Triflupromazine Preferred Concept UI. M0021962. Registry Number. RO16TQF95Y. Related Numbers. 146-54-3. Scope Note. A ... Triflupromazine. Tree Number(s). D02.886.369.918. D03.633.300.783.918. Unique ID. D014273. RDF Unique Identifier. http://id.nlm ...
TRIFLUPROMAZINE HYDROCHLORIDE. TRIFLURIDINE. TRIHEXYPHENIDYL HYDROCHLORIDE. TRILOSTANE. TRIMEPRAZINE TARTRATE. ...
There are several brand names of gabapentin including Gralise, Horizant, and Neurontin. Use only the brand and form of gabapentin your doctor has prescribed.. Gralise (gabapentin) is indicated for the management of postherpetic neuralgia only. It is not used for epilepsy. Gralise comes as a 300 and 600 milligram (mg) extended-release (ER) tablet and in a 30-day starter pack of 78 tablets. A generic option is not yet available.. Horizant (gabapentin enacarbil) is used in adults to treat either nerve pain due to postherpetic neuralgia (PHN) or restless legs syndrome (RLS). Horizont is also an extended-release 300 mg or 600 mg tablet and is not interchangeable with other gabapentin products. A generic option is not yet available.. Neurontin (gabapentin) is an immediate-release form used to treat seizures in adults and children who are at least 3 years old, in addition to nerve pain due to shingles. It comes as 100, 300, or 400 mg oral capsules; 600 mg and 800 mg oral tablets, and as a 250 mg per 5 ...
... triflupromazine, E0228564,Winstrol,stanozolol, E0228566,X-Prep,senna, E0232968,Adumbran,oxazepam, E0232969,Dipidolor, ...
a. Trifl upromazine. b. Trifl uperazine. c. Fluphenazine. d. Prochlorperazine. 2. Extra-pyramidal symptoms are a common side ...
There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page. ...
Triflupromazine; Thioxanthenes: Chlorprothixene • Clopenthixol • Flupentixol • Thiothixene • Zuclopenthixol; Tricyclics: ...
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Triflupromazine. I followed the ...
Triflupromazine D3.494.741.918 D3.633.300.741.918 Trigger Finger Disorder C5.651.869.870.800.800 C5.651.869.816.800 Trillium ...
... triflupromazine, flupenthixol decanoate, fluphenazine, flurazepam, gabapentin, gaboxadol, &ggr;-hydroxybutyrate, haloperidol, ...

No FAQ available that match "triflupromazine"

No images available that match "triflupromazine"